RSV is the most harmful respiratory illness for young infants, says Dr. Jeffrey Pernica, a professor in the Department of ...

RSV and the common cold both cause symptoms of viral infection. Coughing tends to be more severe in RSV. Learn how RSV vs.

This fall and winter, Ontario, Quebec and Nunavut will offer the newer monoclonal antibody nirsevimab — approved by Health ...

Respiratory Syncytial Virus (RSV) remains a critical health issue globally, particularly affecting vulnerable populations ...

AI (in this case, ChatGPT) is an amazing tool for science and medical writers. But it's not perfect. It sometimes makes ...

As the golden season of autumn approaches, it’s time to start thinking about more than just pumpkin spice lattes and cozy ...

Getting vaccinated is one of the most effective ways to protect yourself and your loved ones from the flu, COVID-19 and RSV.

Since the virus that causes COVID-19 mutates rapidly, new variants regularly emerge and vaccines need to be adjusted ...

There’s also palivizumab (Synagis), the first antibody approved for use in kids against RSV. However, palivizumab is recommended only for babies who were born prematurely and are younger than six ...

AstraZeneca Pharma India share price rose 12.5 percent intraday on September 24 to hits 52-week high of 7,595 after the company received permission to import for sale & distribution of Durvalumab ...